ClinVar

Description

The p.Y28C variant (also known as c.83A>G), located in coding exon 2 of the PALB2 gene, results from an A to G substitution at nucleotide position 83. The tyrosine at codon 28 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been reported in a male diagnosed with breast cancer at age 46 who had three female relatives diagnosed with breast cancer (Ding YC et al. Breast Cancer Res. Treat. 2011 Apr; 126(3):771-8). Multiple functional studies have shown that this variant disrupts the interaction between PALB2 and BRCA1 (Rodrigue A et al. Nucleic Acids Res., 2019 11;47:10662-10677; Foo TK et al. Oncogene, 2017 07;36:4161-4170) but are equivocal regarding this variant's ability to disrupt DNA repair (Rodrigue A et al. Nucleic Acids Res., 2019 11;47:10662-10677; Boonen RACM et al. Nat Commun, 2019 11;10:5296; Foo TK et al. Oncogene, 2017 07;36:4161-4170; Wiltshire T et al. Genet Med, 2020 03;22:622-632; Brnich SE et al. J Mol Diagn, 2021 07;23:847-864). Studies investigating sensitivity of cells to DNA damaging agents are also equivocal about this variant's ability to confer sensitivity (Boonen RACM et al. Nat Commun, 2019 11;10:5296; Foo TK et al. Oncogene, 2017 07;36:4161-4170; Rodrigue A et al. Nucleic Acids Res., 2019 11;47:10662-10677). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.